Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea
· Delayed Price · Currency is KRW 5,380.00
0.00 (0.00%)
At close: Mar 28, 2025, 3:30 PM KST
Optipharm.CO.,LTD Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 19,636 | 17,373 | 16,008 | 14,258 | 13,046 | Upgrade
|
| Other Revenue | -0 | - | - | -0 | -0 | Upgrade
|
| Revenue | 19,636 | 17,373 | 16,008 | 14,258 | 13,046 | Upgrade
|
| Revenue Growth (YoY) | 13.03% | 8.52% | 12.27% | 9.29% | -4.45% | Upgrade
|
| Cost of Revenue | 14,741 | 13,177 | 12,293 | 10,522 | 9,539 | Upgrade
|
| Gross Profit | 4,896 | 4,195 | 3,715 | 3,736 | 3,507 | Upgrade
|
| Selling, General & Admin | 3,946 | 3,301 | 2,546 | 2,729 | 2,818 | Upgrade
|
| Research & Development | 2,802 | 2,946 | 3,821 | 5,022 | 3,670 | Upgrade
|
| Other Operating Expenses | 187.32 | 184.01 | 363.43 | 118.5 | 119.01 | Upgrade
|
| Operating Expenses | 7,348 | 6,826 | 7,092 | 8,241 | 6,961 | Upgrade
|
| Operating Income | -2,452 | -2,631 | -3,377 | -4,505 | -3,454 | Upgrade
|
| Interest Expense | -544.33 | -477.34 | -353.51 | -173.78 | -108.33 | Upgrade
|
| Interest & Investment Income | 598.82 | 665.39 | 464.38 | 234.2 | 325.36 | Upgrade
|
| Earnings From Equity Investments | - | -1.49 | -0.35 | -0.29 | -10.44 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.12 | -1.38 | -3.48 | -0.54 | Upgrade
|
| Other Non Operating Income (Expenses) | 39.74 | 6.52 | 1,220 | 1,370 | 881.6 | Upgrade
|
| EBT Excluding Unusual Items | -2,358 | -2,438 | -2,048 | -3,078 | -2,366 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.97 | 1.06 | 3.31 | -1.76 | 13.6 | Upgrade
|
| Pretax Income | -2,357 | -2,437 | -2,045 | -3,080 | -2,352 | Upgrade
|
| Net Income | -2,357 | -2,437 | -2,045 | -3,080 | -2,352 | Upgrade
|
| Net Income to Common | -2,357 | -2,437 | -2,045 | -3,080 | -2,352 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Change (YoY) | -0.28% | 0.22% | 0.82% | 0.66% | 1.30% | Upgrade
|
| EPS (Basic) | -161.00 | -166.00 | -139.60 | -212.00 | -163.00 | Upgrade
|
| EPS (Diluted) | -161.00 | -166.00 | -139.60 | -212.00 | -163.00 | Upgrade
|
| Free Cash Flow | -2,273 | -3,395 | -7,006 | -2,695 | -2,507 | Upgrade
|
| Free Cash Flow Per Share | -155.29 | -231.26 | -478.36 | -185.50 | -173.74 | Upgrade
|
| Gross Margin | 24.93% | 24.15% | 23.21% | 26.20% | 26.88% | Upgrade
|
| Operating Margin | -12.49% | -15.14% | -21.10% | -31.59% | -26.47% | Upgrade
|
| Profit Margin | -12.00% | -14.03% | -12.77% | -21.60% | -18.03% | Upgrade
|
| Free Cash Flow Margin | -11.58% | -19.54% | -43.77% | -18.90% | -19.22% | Upgrade
|
| EBITDA | -837.6 | -1,198 | -2,257 | -3,429 | -2,469 | Upgrade
|
| EBITDA Margin | -4.27% | -6.89% | -14.10% | -24.05% | -18.93% | Upgrade
|
| D&A For EBITDA | 1,614 | 1,433 | 1,120 | 1,076 | 984.42 | Upgrade
|
| EBIT | -2,452 | -2,631 | -3,377 | -4,505 | -3,454 | Upgrade
|
| EBIT Margin | -12.49% | -15.14% | -21.10% | -31.59% | -26.47% | Upgrade
|
| Advertising Expenses | 31.26 | 28.73 | 92.55 | 22.55 | 34.89 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.